BioAge Labs Inc
Research BioAge Labs Inc (BIOA) on Bullrun: market cap USD 1.11B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIOA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 1.11B
- Financial periodFY2025
- RevenueUSD 9.00M
- Net income-USD 80.61M
- Free cash flow-USD 82.35M
Valuation Snapshot
latest market cap is USD 1.11B.
About BioAge Labs Inc
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging.
Frequently asked questions
What is BioAge Labs Inc's market cap?
BioAge Labs Inc's market capitalization is USD 1.11B.
What does BioAge Labs Inc do?
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging.